Delivery Order SPE2DB24D9144-SPE2DB25FCMQD

Award Date 4/22/25
Potential Completion Date 5/13/25
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $13,771.50 firm fixed-price delivery order is for the supply of 4,567,950 units of Botox 200-unit vials. The contract has an ultimate completion date of May 5, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract award, valued at $32,342.50, is for the delivery of 4,567,937,903 units of Botox 200 unit vials. The contract is a firm fixed-price delivery order with a completion date of May 5, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4,556,763,691 units of Botox 100 unit vials, with a total ceiling value of $44,087.00. The contract has a firm fixed price pricing type and a completion date of April 19, 2022. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $34,611.00, is for the delivery of BOTOX 100 unit vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $11,075.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,564,258,790 units of Botox 100 unit vials, with an ultimate completion date of May 1, 2024. This delivery order is part of a larger $4,999,999 indefinite delivery, indefinite quantity (IDIQ) contract that DMS Pharmaceutical Group...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,181.00, is for the delivery of 4,568,188,603 units of Botox 200 unit vials. The contract has an ultimate completion date of May 8, 2025 and was awarded on April 17, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a $8,547.90 firm fixed-price delivery order for 4,566,890,532 units of Botox 200 unit vials, with a performance period ending on January 27, 2025. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group holds a significant $499,999,999 single-award Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $1,845.92 and an ultimate completion date of April 17, 2024. DMS Pharmaceutical Group is supplying Botox 100 unit vials to the DLA under this delivery order, which is part of a larger indefinite delivery contract (IDC) between the company and...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,844.40, is for the delivery of BOTOX 100 unit vials and has an ultimate completion date of September 4, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows the...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $25,874.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of BOTOX 200 unit vials, with a period of performance through July 15, 2024. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) worth up to $499,999,999 with DMS Pharmaceutical Group, which allows the DLA...
  • SPE2DB24D9144
    Indefinite Delivery Contract
  • SPE2DB24D9144-SPE2DB25FCMQD
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,771.50, is for the delivery of 4,568,012,828 units of Botox 200 unit vials. The contract is a firm fixed-price delivery order with a period of performance ending on May 13, 2025. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which allows the agency to issue delivery orders for a range of pharmaceutical products to support military health facilities.

Generated 7/22/25, 9:56 AM